| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/27/2007 | US20070297984 Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses |
| 12/27/2007 | US20070297983 Inhibition of breast carcinoma stem cell growth and metastasis |
| 12/27/2007 | US20070297981 Formulations and methods for treating dry eye |
| 12/27/2007 | US20070297979 Pharmaceutical Compounds |
| 12/27/2007 | DE102006029573A1 Neue Quinazoline als Kinase-Inhibitoren New quinazolines as kinase inhibitors |
| 12/27/2007 | DE102006029445A1 Neue 3-Cyano-chinoline als Kinase-Inhibitoren New 3-cyano-quinolines as kinase inhibitors |
| 12/27/2007 | CA2628661A1 Pyrazine derivatives and uses thereof in renal monitoring |
| 12/26/2007 | EP1869164A2 System and methods for preferentially enhancing activation of rac gtpase in a cell or tissue |
| 12/26/2007 | EP1868655A2 Radioisotope labelled biological compositions, and their use in accelerator mass spectrometry. |
| 12/26/2007 | EP1426353B1 1,3-glyceride compound having two iodophenyl groups |
| 12/26/2007 | CN100357756C A method of using spectral-spatial exitation at magnetic resonance imaging |
| 12/26/2007 | CN100356984C 整联蛋白靶向的影像剂 Integrin targeting imaging agent |
| 12/26/2007 | CN100356983C Biotechnological treating method of biomass for stomach intestine contrast-media |
| 12/21/2007 | WO2007146595A2 Compositions and methods for diagnosis of axial pain with or without radiculopathy |
| 12/21/2007 | WO2007145936A2 System and methods for evaluating the efficacy of appetite-affecting drugs |
| 12/21/2007 | WO2007145682A1 Oral dtpa for radionuclide chelation |
| 12/21/2007 | WO2007106142A3 Process for using optical agents |
| 12/21/2007 | WO2007101979A3 Method of assessing the proliferation or differentiation behaviour of a population of target cells in a biological system |
| 12/21/2007 | WO2007084734A3 Method to determine and biomarker for treatment efficacy with ssri, snri, and sari antidepressants |
| 12/21/2007 | WO2007084486A3 Animal model for assessing copd-related diseases |
| 12/21/2007 | CA2651846A1 Use of p11 to diagnose a p11/5-ht related disorder |
| 12/20/2007 | US20070293579 Use of carp inhibitors for the treatment of heart diseases |
| 12/20/2007 | US20070292967 Assay for Ligands of the Ecdysone Receptor |
| 12/20/2007 | US20070292354 Contrast Agents Encapsulating Systems for Cest Imaging |
| 12/20/2007 | US20070292353 Nanoparticles Comprising an Intracellular Targeting Element and Preparation and Use Thereof |
| 12/20/2007 | US20070292352 derivatives of non-steroidal anti-inflammatory drugs that exhibit selective binding to cyclooxygenase-2 (COX-2) and that comprise functional groups allowing them to be used for medical diagnosis and/or as therapeutic agents; tissue-targeted therapy |
| 12/20/2007 | US20070292351 Assay for efficacy of histone deacetylase inhibitors |
| 12/20/2007 | US20070292350 Method For Testing A Compound For A Therapeutic Effect And A Diagnostic Method |
| 12/20/2007 | US20070292349 Itpks as Modifiers of the Igfr Pathway and Methods of Use |
| 12/20/2007 | US20070292348 Treating Wnt signaling-related diseases, for detecting mammary basal-like cells, for diagnosing basal-like breast cancer, and for inhibiting proliferation of a tumor expressing LRP6 |
| 12/20/2007 | US20070292346 Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk |
| 12/20/2007 | US20070292345 detecting the polypeptide fragments of dystrophin protein cleavage by enteroviral protease 2A as a result of an enteroviral infection (Coxsackievirus infection) in the heart; presence of dystrophin cleavage products in the myocytes or blood of a subject is diagnostic for enteroviral infection |
| 12/19/2007 | EP1867993A1 Silica coated nanoparticles with a metal core |
| 12/19/2007 | EP1866421A2 Methods and composition related to in vivo imaging of gene expression |
| 12/19/2007 | EP1866416A2 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 12/19/2007 | EP1866415A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 12/19/2007 | EP1865993A2 Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization |
| 12/19/2007 | EP1865839A2 Functionalized magnetic nanoparticles and methods of use thereof |
| 12/19/2007 | EP1416965B1 Assay method for alzheimer's disease |
| 12/19/2007 | EP0998308B1 Diagnostic method for the detection of miocardial ischemia |
| 12/19/2007 | CN101091114A Method of manufacturing an auto-calibrating sensor |
| 12/19/2007 | CN101090740A Use of thyroid hormone conversion inhibitors |
| 12/19/2007 | CN101090739A 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 12/19/2007 | CN100355806C Terminal amino oxyethylene block polymer modified Gd coordination compound and its synthesis process |
| 12/18/2007 | US7309812 Mating a transgenic mouse whose genome encodes mouse perlecan, a large multidomain proteoglycan that binds and cross-links extracellular matrix (ECM) components and cell surface molecules, domains, with a second transgenic mouse whose genome encodes the human C terminal of A beta precursor protein |
| 12/18/2007 | US7309759 Indolicidin peptide analogues containing at least two basic amino acids; bactericide |
| 12/13/2007 | WO2007143715A2 Oxygen therapy with ultrasound |
| 12/13/2007 | WO2007143682A2 Systems and methods of delivering fluids to a patient of varying concentration |
| 12/13/2007 | WO2007143637A2 Orientation identification |
| 12/13/2007 | WO2007143141A2 In-vivo optical imaging method including analysis of dynamic images |
| 12/13/2007 | WO2007141537A1 Biomedical materials |
| 12/13/2007 | WO2007140617A1 Magnetosome gene expression in eukaryotic cells |
| 12/13/2007 | WO2007140601A1 Method, materials and apparatus for investigating asthma using dust mite allergen |
| 12/13/2007 | WO2006116021A3 Mri technique based on electron spin resonance and endohedral contrast agent |
| 12/13/2007 | WO2006012641A3 Methods for detecting and treating autoimmune disorders |
| 12/13/2007 | US20070287897 Optical Vascular Function Imaging System and Method for Detection and Diagnosis of Cancerous Tumors |
| 12/13/2007 | US20070286896 Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting Liposome |
| 12/13/2007 | US20070286810 Nanoparticles comprising lanthanide chelates |
| 12/13/2007 | US20070286809 Oxygen therapy with ultrasound |
| 12/13/2007 | US20070286808 Method for display presentation of lymph nodes |
| 12/13/2007 | US20070286807 Method Of Inducing Or Modulating Immune Response |
| 12/13/2007 | US20070286805 Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof |
| 12/13/2007 | US20070286804 Method, materials and apparatus for investigating asthma using dust mite allergen |
| 12/13/2007 | US20070286801 2-[18F]fluoro-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide; imaging probes (11C, 123I, 125I, 73Se, 76Br, 77Br, 18F, deuterium) for positron emission tomography (PET); greater sensitivity, resolution; quantitative measurement; antiinflammatory agent, disorder with elevated cyclooxygenase-2 level |
| 12/13/2007 | CA2678285A1 Method, materials and apparatus for investigating asthma using dust mite allergen |
| 12/13/2007 | CA2655118A1 Magnetosome gene expression in eukaryotic cells |
| 12/13/2007 | CA2654316A1 Oxygen therapy with ultrasound |
| 12/12/2007 | EP1865430A2 Monte Carlo simulation using GPU units on personal computers |
| 12/12/2007 | EP1864968A1 Complex compound and mri probe made of same |
| 12/12/2007 | EP1863940A2 Method of risk management for patients undergoing natalizumab treatment |
| 12/12/2007 | EP1863848A2 Antibodies and related molecules that bind to 161p2f10b proteins |
| 12/12/2007 | EP0769967B1 Conjugates comprising an antitumour agent and their use |
| 12/12/2007 | CN101085364A Method for detecting mammary cancer armpit lymph gland transferring focus |
| 12/12/2007 | CN101085342A Method of detecting rhCNTF medicament activity by normal rat weight loss method |
| 12/12/2007 | CN100354980C Apparatus and method for brachytherapy |
| 12/12/2007 | CN100354007C Skeleton tablet core for digestive tract evacuation-detecting slow-release tablet and its preparing process |
| 12/12/2007 | CN100354006C Digestive tract evacuation-detecting slow-release tablet and its preparing process |
| 12/12/2007 | CN100354005C Compound ablation mixture and its use in preparation of drugs for treating tumors |
| 12/11/2007 | US7306787 Engineered particles and methods of use |
| 12/11/2007 | US7306786 Calcium phosphate cements comprising a water-soluble contrast agent |
| 12/11/2007 | US7306784 Complexing; drug delivery; in situ imaging |
| 12/11/2007 | US7306783 Complexing; drug delivery; in situ imaging; detection apoptosis |
| 12/11/2007 | CA2120002C Cytodiagnostic method using alstonine as a selective marker, and diagnostic kit containing said marker |
| 12/06/2007 | WO2007140410A2 Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| 12/06/2007 | WO2007140249A1 Methods of treating stroke |
| 12/06/2007 | WO2007138291A2 Novel imaging agents |
| 12/06/2007 | WO2007045903A3 Methods of analysing cell behaviour |
| 12/06/2007 | WO2007019055A3 Cell delivery fluid for prevention of cellsettling in delivery system |
| 12/06/2007 | WO2005086612A3 Fluorinated carbohydrate conjugates |
| 12/06/2007 | WO2004064109A3 Water soluble metal and semiconductor nanoparticle complexes |
| 12/06/2007 | US20070282012 Reagent for Lacrimation Examination and Method of Lacrimation Examination |
| 12/06/2007 | US20070280889 Contrast agent system for x-ray imaging |
| 12/06/2007 | US20070280887 System and methods for evaluating efficacy of appetite-affecting drugs |
| 12/06/2007 | US20070280884 Insect poison allergens with reduced IgE reactivity and method for producing the same |
| 12/06/2007 | US20070280882 Engineered anti-cd20 antibody fragments for in vivo targeting and therapeutics |
| 12/06/2007 | US20070280879 Therapeutic Use Of Rm1 Antigen |
| 12/06/2007 | US20070280406 Orientation identification |
| 12/06/2007 | CA2652815A1 Methods of treating stroke |
| 12/05/2007 | EP1017318B1 Method of imaging cell death in vivo |
| 12/05/2007 | EP0975374B1 Radiometal-binding peptide analogues |